Get started
RocketTickers

FDA approves Lyumjev(TM) (insulin lispro-aabc injection), Lilly'

Long
Eli Lilly and Company (NYSE:LLY)  
RocketTickers  
NYSE:LLY   Eli Lilly and Company
Beyond Technical Analysis
5
0
beyondta
LLY: Eli Lilly and Company
2020-06-15 22:21:00
FDA approves Lyumjev(TM) (insulin lispro-aabc injection), Lilly's new rapid-acting insulin
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.